Product no. | Product name | Clone | Isotype | Preparation | Amount |
MAB_0010 | Anti- ceramide | S58-9 | IgM | ascites | 0.1 ml |
MAB_0010 | Anti- ceramide | S58-9 | IgM | ascites | 0.2 ml |
MAB_0010 | Anti- ceramide | S58-9 | IgM | ascites | 0.5 ml |
MAB_0011 | Anti- ceramide | S58-9 | IgM | serum-free supernatant | 0.2 ml |
MAB_0011 | Anti- ceramide | S58-9 | IgM | serum-free supernatant | 0.4 ml |
MAB_0011 | Anti- ceramide | S58-9 | IgM | serum-free supernatant | 1.0 ml |
MAB_0012 | Anti- ceramide | S58-9 | IgM | FCS-containing supernatant | 1.0 ml |
MAB_0012 | Anti- ceramide | S58-9 | IgM | FCS-containing supernatant | 2.0 ml |
MAB_0012 | Anti- ceramide | S58-9 | IgM | FCS-containing supernatant | 5.0 ml |
MAB_0013 | Anti- ceramide | S58-9 | IgM | Miniperm | 0.1 ml |
MAB_0013 | Anti- ceramide | S58-9 | IgM | Miniperm | 0.2 ml |
MAB_0013 | Anti- ceramide | S58-9 | IgM | Miniperm | 0.5 ml |
MAB_0014 | Anti- ceramide | S58-9 | IgM | affi-purified | 25 µg |
MAB_0014 | Anti- ceramide | S58-9 | IgM | affi-purified | 50 µg |
MAB_0014 | Anti- ceramide | S58-9 | IgM | affi-purified | 100 µg |
Product no. | Product name | Species | Preparation | Amount |
RAS_0010 | Rabbit Anti-GlcCer | Rabbit | full serum | 0.1 ml |
RAS_0010 | Rabbit Anti-GlcCer | Rabbit | full serum | 0.2 ml |
RAS_0010 | Rabbit Anti-GlcCer | Rabbit | full serum | 0.5 ml |
RAS_0011* | Rabbit Anti-GlcCer | Rabbit | affi-pure IgG | 0.25 mg |
RAS_0011* | Rabbit Anti-GlcCer | Rabbit | affi-pure IgG | 0.50 mg |
RAS_0011* | Rabbit Anti-GlcCer | Rabbit | affi-pure IgG | 1.0 mg |
RAS_0030 | Rabbit Anti- | Rabbit | full serum | 0.1 ml |
RAS_0030 | Rabbit Anti- | Rabbit | full serum | 0.2 ml |
RAS_0030 | Rabbit Anti- | Rabbit | full serum | 0.5 ml |
MAS_0090 | Mouse Anti- | Mouse | full serum | 0.1 ml |
MAS_0090 | Mouse Anti- | Mouse | full serum | 0.2 ml |
MAS_0090 | Mouse Anti- | Mouse | full serum | 0.5 ml |
Product no. | Product name | Amount µg | Price € | Description | Chemical structure |
OS_1 | Kdo allylglycoside, cysteamine spacer | 100 | 200 | obtained by condensation of the allylglycoside with cysteamine; ligand for coupling procedures | ?Kdo-(CH2)3-S-(CH2)2-NH2 |
OS_2 | 2-4-Kdo2 allylglycoside, cysteamine spacer | 100 | 250 | obtained by condensation of the allylglycoside with cysteamine; ligand for coupling procedures | ?Kdo(2"4)?Kdo-(CH2)3-S-(CH2)2-NH2 |
OS_3 | 2-8-Kdo2 allylglycoside, cysteamine spacer | 100 | 250 | obtained by condensation of the allylglycoside with cysteamine; ligand for coupling procedures | aKdo(2"8)?Kdo-(CH2)3-S-(CH2)2-NH2 |
OS_4 | 2-8/2-4-Kdo3 allylglycoside, cysteamine spacer | 100 | 300 | obtained by condensation of the allylglycoside with cysteamine; ligand for coupling procedures | ?Kdo(2"8)?Kdo(2"4)?Kdo-(CH2)3-S-(CH2)2-NH2 |
電話
QQ咨詢
4006551678